CIRM Funded Clinical Trials
A Phase I/IIa Study to Evaluate the Efficacy of Toca 511/Toca FC with Standard of Care Therapy in Newly Diagnosed High Grade Glioma
Disease Area:
Trial Sponsor:
University of California, San Francisco
Trial Stage:
Phase 1
Trial Status:
Launching
Targeted Enrollment:
N/A
